These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. PcG proteins, DNA methylation, and gene repression by chromatin looping. Tiwari VK; McGarvey KM; Licchesi JD; Ohm JE; Herman JG; Schübeler D; Baylin SB PLoS Biol; 2008 Dec; 6(12):2911-27. PubMed ID: 19053175 [TBL] [Abstract][Full Text] [Related]
3. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival. Balasubramanian S; Adhikary G; Eckert RL Carcinogenesis; 2010 Mar; 31(3):496-503. PubMed ID: 20015867 [TBL] [Abstract][Full Text] [Related]
4. Inner workings and regulatory inputs that control Polycomb repressive complex 2. O'Meara MM; Simon JA Chromosoma; 2012 Jun; 121(3):221-34. PubMed ID: 22349693 [TBL] [Abstract][Full Text] [Related]
5. The phosphatase interactor NIPP1 regulates the occupancy of the histone methyltransferase EZH2 at Polycomb targets. Van Dessel N; Beke L; Görnemann J; Minnebo N; Beullens M; Tanuma N; Shima H; Van Eynde A; Bollen M Nucleic Acids Res; 2010 Nov; 38(21):7500-12. PubMed ID: 20671031 [TBL] [Abstract][Full Text] [Related]
6. EZH2 methyltransferase and H3K27 methylation in breast cancer. Yoo KH; Hennighausen L Int J Biol Sci; 2012; 8(1):59-65. PubMed ID: 22211105 [TBL] [Abstract][Full Text] [Related]
7. The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing. Nuytten M; Beke L; Van Eynde A; Ceulemans H; Beullens M; Van Hummelen P; Fuks F; Bollen M Oncogene; 2008 Feb; 27(10):1449-60. PubMed ID: 17724462 [TBL] [Abstract][Full Text] [Related]
8. Polycomb group protein-associated chromatin is reproduced in post-mitotic G1 phase and is required for S phase progression. Aoto T; Saitoh N; Sakamoto Y; Watanabe S; Nakao M J Biol Chem; 2008 Jul; 283(27):18905-15. PubMed ID: 18453536 [TBL] [Abstract][Full Text] [Related]
9. A model for transmission of the H3K27me3 epigenetic mark. Hansen KH; Bracken AP; Pasini D; Dietrich N; Gehani SS; Monrad A; Rappsilber J; Lerdrup M; Helin K Nat Cell Biol; 2008 Nov; 10(11):1291-300. PubMed ID: 18931660 [TBL] [Abstract][Full Text] [Related]
10. SSX2 is a novel DNA-binding protein that antagonizes polycomb group body formation and gene repression. Gjerstorff MF; Relster MM; Greve KB; Moeller JB; Elias D; Lindgreen JN; Schmidt S; Mollenhauer J; Voldborg B; Pedersen CB; Brückmann NH; Møllegaard NE; Ditzel HJ Nucleic Acids Res; 2014 Oct; 42(18):11433-46. PubMed ID: 25249625 [TBL] [Abstract][Full Text] [Related]
12. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Cao R; Wang L; Wang H; Xia L; Erdjument-Bromage H; Tempst P; Jones RS; Zhang Y Science; 2002 Nov; 298(5595):1039-43. PubMed ID: 12351676 [TBL] [Abstract][Full Text] [Related]
13. EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor. Hwang C; Giri VN; Wilkinson JC; Wright CW; Wilkinson AS; Cooney KA; Duckett CS Breast Cancer Res Treat; 2008 Jan; 107(2):235-42. PubMed ID: 17453341 [TBL] [Abstract][Full Text] [Related]
14. Polycomb repressive complex 2 targets murine cytomegalovirus chromatin for modification and associates with viral replication centers. Abraham CG; Kulesza CA PLoS One; 2012; 7(1):e29410. PubMed ID: 22279536 [TBL] [Abstract][Full Text] [Related]
15. The Polycomb group protein EZH2 directly controls DNA methylation. Viré E; Brenner C; Deplus R; Blanchon L; Fraga M; Didelot C; Morey L; Van Eynde A; Bernard D; Vanderwinden JM; Bollen M; Esteller M; Di Croce L; de Launoit Y; Fuks F Nature; 2006 Feb; 439(7078):871-4. PubMed ID: 16357870 [TBL] [Abstract][Full Text] [Related]
16. The E2F6 Transcription Factor is Associated with the Mammalian SUZ12-Containing Polycomb Complex. Shirahama Y; Yamamoto K Kurume Med J; 2023 Feb; 67(4):171-183. PubMed ID: 36464274 [TBL] [Abstract][Full Text] [Related]
17. The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer. Zeidler M; Kleer CG J Mol Histol; 2006 Sep; 37(5-7):219-23. PubMed ID: 16855786 [TBL] [Abstract][Full Text] [Related]
18. The polycomb repressive complex 2 is a potential target of SUMO modifications. Riising EM; Boggio R; Chiocca S; Helin K; Pasini D PLoS One; 2008 Jul; 3(7):e2704. PubMed ID: 18628979 [TBL] [Abstract][Full Text] [Related]
19. The knock-down of overexpressed EZH2 and BMI-1 does not prevent osteosarcoma growth. Sasaki H; Setoguchi T; Matsunoshita Y; Gao H; Hirotsu M; Komiya S Oncol Rep; 2010 Mar; 23(3):677-84. PubMed ID: 20127006 [TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells. Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]